| | | | | | | Sponsored | | The lab is the cornerstone of healthcare, but are your tests right for you & your patients? Some tests can be slow, costly, or labor-intensive. For patients with overlapping symptoms, having one size fits all tests might be right for one patient but may not suit all. Join Hologic at the ASM or ADLM meetings to learn how flexible testing can help. |
|
|
|
| |
| | |
|
|
| | | | | | Early diagnosis and intervention are causing more Americans to survive cancer, according to an American Cancer Society (ACS) analysis. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | For the 7th consecutive year, the Black Book Market Research User Survey has ranked Orchard Software as the top laboratory information system (LIS) vendor. “Receiving the Black Book award is a welcome recognition of the hard work our teams put into continually developing innovative solutions that the laboratory can rely on to support patient care,” said Billie Whitehurst, CEO of Orchard Software. |
|
|
|
| |
| | |
|
|
| | | | | | Medical Laboratory Observer is now conducting its annual Salary Survey, and we want to hear from you. |
|
|
|
| |
| | |
|
|
| | | | | | The American Hospital Association (AHA) published an analysis of the liability of violence to U.S. Hospitals. The analysis was written by The University of Washington's Harborview Injury and Prevention Research Center. |
|
|
|
| |
| | |
|
|
| | | | | | InStride has facilitated a unique partnership between Arizona State University’s College of Health Solutions and Labcorp to launch a Master of Science in Cytology. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Unlock reproducible results with authenticated ATCC biomaterials. With a century of cell culture experience, ATCC offers over 4,000 immortalized and primary cells, assay ready cells and pre-plated spheroids, organoids, reporter-labeled cells, stem cells, sera, and media. Level up your labwork with the trusted leader in cell biology. |
|
|
|
| |
| | |
|
|
| | | | | | Foresight Diagnostics announced a strategic, worldwide partnership with QIAGEN to develop and commercialize a kit-based version of Foresight’s CLARITY assay, with the goal of enabling global in vitro diagnostic and companion diagnostic applications in lymphoma and other hematological malignancies. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|